REGN - Regeneron multiple myeloma therapy accepted for EU review
2024-02-02 07:17:52 ET
More on Regeneron
- Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)
- Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade)
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Regeneron posts Q4 beat even as Eylea, COVID-19 sales dip
- Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook